Skip to main content
Erschienen in: Annals of Hematology 2/2010

01.02.2010 | Original Article

Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups

verfasst von: Reem Ameen, Kamlesh P. Sajnani, Amani Albassami, Samar Refaat

Erschienen in: Annals of Hematology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

There is a wide variation in the prevalence of various subtypes of non-Hodgkin’s lymphoma worldwide. The aim of this study was to determine the relative frequency of different subtypes of non-Hodgkin’s lymphoma in Kuwait based on the Revised European–American Lymphoma (REAL) classification. From 1998 to 2006, 738 subjects were included that were registered with non-Hodgkin’s lymphoma in the population-based cancer registry at the Kuwait Cancer Control Center. Expert pathologists reviewed histological slides from all subjects. We performed detailed immunohistochemical studies and classified subjects based on the REAL classification. The prevalence of different types of non-Hodgkin's lymphoma was determined based on age, sex, site of disease, and ethnicity. Ethnicity groups comprised Kuwaiti Arabs, non Kuwaiti Arabs, Asians, and others. The prevalence of B- and T-cell lymphomas was 81.8% and 14.2%, respectively. The most common age group was 41–60 years old. The three most common subtypes in Kuwaiti Arabs were diffuse large B-cell lymphoma (46.5%), follicular lymphoma (15.5%), and mycosis fungoides (9.3%). In non-Kuwaiti Arabs, the most common subtypes were diffuse large B-cell lymphoma (48%), B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia (15.8%), and follicular lymphoma (12.7%). Overall, non-Kuwaiti Arabs exhibited the highest prevalence (59%), and 54% of all cases had extranodal presentation. Compared to the Western world, Kuwait had a lower prevalence of follicular lymphoma, a higher prevalence of diffuse large B-cell lymphoma and extranodal presentation, and a high frequency of mycosis fungoides. Compared to other parts of Asia, Kuwait had a lower frequency of peripheral T-cell lymphomas.
Literatur
1.
Zurück zum Zitat Cartwright R, Brincker H, Carli PM, Clayden D et al (1999) The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 35:627–633CrossRefPubMed Cartwright R, Brincker H, Carli PM, Clayden D et al (1999) The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 35:627–633CrossRefPubMed
2.
Zurück zum Zitat Coleman MP, Damiecki P, Arslan A, Renard H (1993) Trends in cancer incidence and mortality. IARC Scientific Publications No. 121. IARC, Lyon Coleman MP, Damiecki P, Arslan A, Renard H (1993) Trends in cancer incidence and mortality. IARC Scientific Publications No. 121. IARC, Lyon
3.
Zurück zum Zitat Cartwright RA (1992) Changes in the descriptive epidemiology of non-Hodgkin’s lymphoma in Great Britain? Cancer Res 52(Suppl):5441s–5442sPubMed Cartwright RA (1992) Changes in the descriptive epidemiology of non-Hodgkin’s lymphoma in Great Britain? Cancer Res 52(Suppl):5441s–5442sPubMed
4.
Zurück zum Zitat Holford T, Zheng 1, Mayne S1, McKay LA (1992) Time trends of non-Hodgkin’s lymphoma. Are they real? What do they mean? Cancer Res 52(Suppl):5443s–5446sPubMed Holford T, Zheng 1, Mayne S1, McKay LA (1992) Time trends of non-Hodgkin’s lymphoma. Are they real? What do they mean? Cancer Res 52(Suppl):5443s–5446sPubMed
5.
Zurück zum Zitat Devesa SS, Silverman DT, Young JL, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF (1987) Cancer incidence and mortality trends among whites in the United States. 1947–84. J.Nati Cancer Inst 79:701–770 Devesa SS, Silverman DT, Young JL, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF (1987) Cancer incidence and mortality trends among whites in the United States. 1947–84. J.Nati Cancer Inst 79:701–770
6.
Zurück zum Zitat Wingo PA, Tong T, Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45(8–30):1995 Wingo PA, Tong T, Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45(8–30):1995
7.
Zurück zum Zitat Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52(Suppl):5432s–5440sPubMed Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52(Suppl):5432s–5440sPubMed
8.
Zurück zum Zitat Zheng T, MST BP, Holford TR, Liu WL, Flannery J (1991) Epidemiology of non-Hodgkin’s lymphoma in Connecticut. Cancer (Phila.) 70:840–849CrossRef Zheng T, MST BP, Holford TR, Liu WL, Flannery J (1991) Epidemiology of non-Hodgkin’s lymphoma in Connecticut. Cancer (Phila.) 70:840–849CrossRef
9.
Zurück zum Zitat National Cancer Institute (NCI) (1993) SEER cancer statistics review 1973–1990. NIH Publication No. 93–2789. National Cancer Institute, Bethesda National Cancer Institute (NCI) (1993) SEER cancer statistics review 1973–1990. NIH Publication No. 93–2789. National Cancer Institute, Bethesda
10.
Zurück zum Zitat Barnes N, Cartwright RA, O’Brien C, Richards IDG, Roberts B, Bird CC (1986) Rising incidence of lymphoid malignancies -true or false? Br J Cancer 53:393–398PubMed Barnes N, Cartwright RA, O’Brien C, Richards IDG, Roberts B, Bird CC (1986) Rising incidence of lymphoid malignancies -true or false? Br J Cancer 53:393–398PubMed
11.
Zurück zum Zitat Lee HP, Duffy SW, Day EN, Shanmugaratnam K (1988) Recent trends in cancer incidence among Singapore Chinese. Int J Cancer 52:159–166CrossRef Lee HP, Duffy SW, Day EN, Shanmugaratnam K (1988) Recent trends in cancer incidence among Singapore Chinese. Int J Cancer 52:159–166CrossRef
12.
Zurück zum Zitat Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (Bethesda) 94:1204–1210 Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (Bethesda) 94:1204–1210
13.
Zurück zum Zitat Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A (1999) A population based, case control study of non-Hodgkin’s lymphoma in patients with rheumatoid arthritis. J Rheumatol 26:1676–1680PubMed Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A (1999) A population based, case control study of non-Hodgkin’s lymphoma in patients with rheumatoid arthritis. J Rheumatol 26:1676–1680PubMed
15.
Zurück zum Zitat Armitage JO, Weisenburger DD (1998) New approach to classifying non-Hodgkin’s lymphomas: clinical features of major histologic subtypes. JCO 16:2780–2795 Armitage JO, Weisenburger DD (1998) New approach to classifying non-Hodgkin’s lymphomas: clinical features of major histologic subtypes. JCO 16:2780–2795
16.
Zurück zum Zitat Anderson JR, Armitage JO, Weisenburger DD (1998) Epidemiology of non-Hodgkin’s lymphomas: distribution of the major subtypes differs by geographic locations. Ann Oncol 9:717–720CrossRefPubMed Anderson JR, Armitage JO, Weisenburger DD (1998) Epidemiology of non-Hodgkin’s lymphomas: distribution of the major subtypes differs by geographic locations. Ann Oncol 9:717–720CrossRefPubMed
17.
Zurück zum Zitat Naresh KN, Srinivas V, Soman CS (2000) Distribution of various subtypes of non-Hodgkin’s lymphoma in India: a study of 2772 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol 11(Suppl 1):S63–S67CrossRef Naresh KN, Srinivas V, Soman CS (2000) Distribution of various subtypes of non-Hodgkin’s lymphoma in India: a study of 2772 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol 11(Suppl 1):S63–S67CrossRef
18.
Zurück zum Zitat Young-Hyeh K, Chul-Woo K, Sun-Woo K et al (1998) REAL Classification of malignant lymphomas in Republic of Korea. Cancer 83(4):806–812CrossRef Young-Hyeh K, Chul-Woo K, Sun-Woo K et al (1998) REAL Classification of malignant lymphomas in Republic of Korea. Cancer 83(4):806–812CrossRef
19.
Zurück zum Zitat Salem P, Anaissie E, Khalyl M et al (1986) Non-Hodgkin’s lymphomas in the Middle East. A study of 417 patients with emphasis on special features. Cancer 58(5):1162–1166CrossRefPubMed Salem P, Anaissie E, Khalyl M et al (1986) Non-Hodgkin’s lymphomas in the Middle East. A study of 417 patients with emphasis on special features. Cancer 58(5):1162–1166CrossRefPubMed
20.
Zurück zum Zitat Al Shemmari S, Ameen R, Sajnani KP (2008) Extranodal lymphoma: a comparative study. Hematology 13:3 Al Shemmari S, Ameen R, Sajnani KP (2008) Extranodal lymphoma: a comparative study. Hematology 13:3
21.
Zurück zum Zitat Newton R, Ferlay J, Beral V, Devesa SS (1997) The epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 72:923–930CrossRefPubMed Newton R, Ferlay J, Beral V, Devesa SS (1997) The epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 72:923–930CrossRefPubMed
22.
Zurück zum Zitat Kuwait Cancer Registry, Annual Report (2002) Ministry of Health, State of Kuwait Kuwait Cancer Registry, Annual Report (2002) Ministry of Health, State of Kuwait
Metadaten
Titel
Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups
verfasst von
Reem Ameen
Kamlesh P. Sajnani
Amani Albassami
Samar Refaat
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 2/2010
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0801-z

Weitere Artikel der Ausgabe 2/2010

Annals of Hematology 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.